Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James A. Gow
Observed names:
Gow, James,
J A Gow,
J. A. Gow,
J.A. Gow,
JAMES A. GOW,
James A Gow
show all 6
Institution:
Biogen (United States)
Observed institutions:
Biogen (United States),
Inotek Pharmaceuticals (United States),
Rivian,
State of California,
Bausch + Lomb (United States)
OpenAlex ID:
A5114260313
Bromfenac Ophthalmic Solution 0.09% (Xibrom) for Postoperative Ocular Pain and Inflammation
2007
·
Eric D. Donnenfeld
, Edward J. Holland
, et al.
·
Ophthalmology
·
104
Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations
2023
·
Lenore von Krusenstiern
, Jiajun Liu
, et al.
·
JAMA Ophthalmology
·
76
PDF
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial
2023
·
Robert E. MacLaren
, M. Dominik Fischer
, et al.
·
Nature Medicine
·
72
PDF
24-Hour Evaluation of the Ocular Distribution of 14 C-Labeled Bromfenac Following Topical Instillation into the Eyes of New Zealand White Rabbits
2008
·
George A. Baklayan
, Hal M. Patterson
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
65
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
2024
·
Byron L. Lam
, Mark E. Pennesi
, et al.
·
Ophthalmology
·
58
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children
2009
·
Mark B. Abelson
, Gail L. Torkildsen
, et al.
·
Clinical Therapeutics
·
54
Bromfenac Ophthalmic Solution 0.07% Dosed Once Daily for Cataract Surgery
2013
·
Thomas R. Walters
, Damien F. Goldberg
, et al.
·
Ophthalmology
·
46
Safety and Efficacy of Bromfenac Ophthalmic Solution (Bromday) Dosed Once Daily for Postoperative Ocular Inflammation and Pain
2011
·
Bonnie A. Henderson
, Johnny L. Gayton
, et al.
·
Ophthalmology
·
39
Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain
2011
·
Steven M. Silverstein
, Melissa G. Cable
, et al.
·
Current Medical Research and Opinion
·
36
Multicenter Clinical Evaluation of Bepotastine Besilate Ophthalmic Solutions 1.0% and 1.5% to Treat Allergic Conjunctivitis
2010
·
Thomas T. Macejko
, Mark T. Bergmann
, et al.
·
American Journal of Ophthalmology
·
33
Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate
2010
·
Jon I. Williams
, James A. Gow
, et al.
·
Current Medical Research and Opinion
·
32
The Systemic Safety of Bromfenac Ophthalmic Solution 0.09%
2007
·
Robert H. Stewart
, Lisa R. Grillone
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
28
Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge
2010
·
Gail L. Torkildsen
, Jon I. Williams
, et al.
·
Annals of Allergy Asthma & Immunology
·
24
Ocular Pharmacokinetics of a Single Dose of Bromfenac Sodium Ophthalmic Solution 0.1% in Human Aqueous Humor
2008
·
Kensaku Miyake
, Takahiro Ogawa
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
24
Prolonged Effectiveness of Bepotastine Besilate Ophthalmic Solution for the Treatment of Ocular Symptoms of Allergic Conjunctivitis
2011
·
Jon I. Williams
, Kathryn S. Kennedy
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
22
Inclusive Conjunctivitis With Hearing Loss
1974
·
J.A. Gow
, H B Ostler
, et al.
·
JAMA
·
16
XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa
2024
·
Robert E. MacLaren
, Jacque L. Duncan
, et al.
·
Ophthalmology Science
·
15
PDF
Intraocular Extension of an Epibulbar Malignant Melanoma
1973
·
J. A. Gow
, W. H. Spencer
·
Archives of Ophthalmology
·
15
Efficacy of bepotastine besilate ophthalmic solution 1.5% for seasonal allergic conjunctivitis: A randomized, placebo-controlled, natural exposure, clinical trial
2013
·
Warner W. Carr
, Anjuli S. Nayak
, et al.
·
Allergy and Asthma Proceedings
·
13
Predicting Response of Vitreous Hemorrhage after Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase) in Patients with Diabetes
2008
·
Abdhish R. Bhavsar
, Lisa R. Grillone
, et al.
·
Investigative Ophthalmology & Visual Science
·
13
A Prospective, Observational, Non-interventional Clinical Study of Participants With Choroideremia: The NIGHT Study
2024
·
ROBERT E. MACLAREN
, BYRON L. LAM
, et al.
·
American Journal of Ophthalmology
·
10
Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis
2012
·
Edward J. Meier
, Gail L. Torkildsen
, et al.
·
Allergy and Asthma Proceedings
·
10
Excimer Photorefractive Keratectomy After Undercorrected Radial Keratotomy
1995
·
Marvin L Kwitko
, James A Gow
, et al.
·
Journal of Refractive Surgery
·
9
Prospective Evaluation of Outcomes in Patients Undergoing Treatment for Myopia Using the WaveLight Refractive Suite
2017
·
Arthur Cummings
, Daniel Durrie
, et al.
·
Journal of Refractive Surgery
·
7
Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Ocular Itching in a Clinical Model of Allergic Conjunctivitis
2009
·
G.L. Torkildsen
, P.J. Gomes
, et al.
·
Journal of Allergy and Clinical Immunology
·
4
Show more works
View as search
Works count:
42
Citation count:
840
H-index:
16
I10-index:
22
Year
Topic
Type